CINECA IRIS Institutional Research Information System

CAPPELLO, EMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.145
AS - Asia 1.030
EU - Europa 881
SA - Sud America 160
AF - Africa 74
OC - Oceania 14
Totale 3.304
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.103
SG - Singapore 376
IT - Italia 272
CN - Cina 248
SE - Svezia 152
HK - Hong Kong 147
BR - Brasile 128
DE - Germania 96
IN - India 83
GB - Regno Unito 81
FI - Finlandia 72
FR - Francia 45
NL - Olanda 39
VN - Vietnam 35
CI - Costa d'Avorio 31
JP - Giappone 30
BG - Bulgaria 28
TR - Turchia 22
KR - Corea 20
CA - Canada 19
RU - Federazione Russa 19
PL - Polonia 18
AU - Australia 14
MX - Messico 14
AT - Austria 13
SN - Senegal 13
AR - Argentina 11
ID - Indonesia 11
BD - Bangladesh 9
IR - Iran 9
CZ - Repubblica Ceca 8
LT - Lituania 8
NG - Nigeria 8
ZA - Sudafrica 8
EC - Ecuador 5
CL - Cile 4
IQ - Iraq 4
JO - Giordania 4
PK - Pakistan 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
CO - Colombia 3
DK - Danimarca 3
DZ - Algeria 3
IE - Irlanda 3
IL - Israele 3
JM - Giamaica 3
LV - Lettonia 3
MA - Marocco 3
MY - Malesia 3
PT - Portogallo 3
PY - Paraguay 3
UA - Ucraina 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BE - Belgio 2
CH - Svizzera 2
ES - Italia 2
ET - Etiopia 2
GH - Ghana 2
GR - Grecia 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JE - Jersey 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MK - Macedonia 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
SI - Slovenia 1
SO - Somalia 1
TW - Taiwan 1
Totale 3.304
Salva come PNG Salva come JPEG
Città #
Ashburn 223
Singapore 203
Hong Kong 145
Dallas 142
Santa Clara 142
Shanghai 92
Munich 56
Boardman 55
Los Angeles 46
Chandler 44
Florence 44
Beijing 40
Pisa 37
New York 36
Helsinki 35
London 35
Abidjan 31
Sofia 28
Turku 28
Serra 27
Kent 20
Massa 19
Princeton 17
Hyderabad 16
Mumbai 16
Fairfield 15
Istanbul 15
Frankfurt am Main 14
Tokyo 14
Dakar 13
Lawrence 13
Buffalo 12
Warsaw 12
Hefei 11
Rome 11
Denver 10
Hanoi 10
Ho Chi Minh City 9
Medford 9
Milan 9
Ogden 9
Redondo Beach 9
Wilmington 9
Chicago 8
Fuzhou 8
Lagos 8
San Francisco 8
Atlanta 7
Houston 7
Jakarta 7
Mexico City 7
Nuremberg 7
Amsterdam 6
Bengaluru 6
Chennai 6
Jeju City 6
Johannesburg 6
Lappeenranta 6
Lauterbourg 6
Phoenix 6
Rio de Janeiro 6
Washington 6
Belo Horizonte 5
Brooklyn 5
Cambridge 5
Düsseldorf 5
Livorno 5
Marseille 5
New Malden 5
Poplar 5
Prague 5
Quanzhou 5
Roubaix 5
Seoul 5
São Paulo 5
Vancouver 5
Amman 4
Birmingham 4
Buenos Aires 4
Cascina 4
Council Bluffs 4
Ottawa 4
Paris 4
Pomona 4
Redwood City 4
Scarlino 4
Vienna 4
Baku 3
Brasília 3
Brescia 3
Bresso 3
Curitiba 3
Dublin 3
Esslingen am Neckar 3
Groningen 3
Jamshedpur 3
Kariya 3
Kolkata 3
Manchester 3
Melbourne 3
Totale 2.061
Salva come PNG Salva come JPEG
Nome #
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 171
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study 160
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 139
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs 132
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline 131
Raynaud’s Phenomenon Associated with Calcitonin Gene-Related Peptide (CGRP) Antagonists: a Disproportionality Analysis on VigiBase 128
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database 123
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 120
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 120
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 118
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study 113
Disproportionality Analysis of ‘‘Early-Onset’’ Tardive Dyskinesia Stratified by Time to Onset Using FAERS Database. 108
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future 107
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients 104
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 104
Erratum to: Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System (Drug Safety, (2023), 46, 3, (283-295), 10.1007/s40264-022-01269-x) 99
Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients 97
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis 96
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance 92
Analysis of the Drug Related Emergency Department Admissions in Tuscany: The FARO Project 88
Fatal Fat Overload Syndrome Following Intravenous Lipid Emulsion Administration as Antidote in Suspected Anesthetic Intoxication: A Fatal Medication Error. 88
Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study 83
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 80
Assessment of Healthcare Facilities Associated with JAKi Drugs Used in Rheumatoid Arthritis Patients in Tuscany, Italy: The LEONARDO 72
Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use 72
Oral Presentation: Signal of Hypertension Associated with COVID-19 Vaccination: VigiBase (R) Data and Evidence from Real World 72
Supporting the Spontaneous Reporting by Health Care Professionals of the University Hospital of Pisa, Italy: a Pilot Project from the Unit of Adverse Drug Reactions Monitoring 70
Communicating Drug Safety 66
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence 64
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option 60
Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall 57
Oral Presentation: Accesses to Emergency Department and Hospitalizations in New Users of Biologic Therapies for Ulcerative Colitis in Tuscany: The MICHELANGELO Study 57
COVID-19 Vaccines and Thromboembolic Events with Thrombocytopenia: Data from Italian Pharmacovigilance Public Database 57
Signals of Possibly Persistent Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Disproportionality Analysis Using the EudraVigilance Database 52
Unresolved Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Signal Detection Analysis on Publicly Accessible Eudravigilance Data 44
Pharmacological Phase I Clinical Trials in Pediatric Brain Tumors (1990–2024): A Historical Perspective 12
Totale 3.356
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.667
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 6 22
2021/2022279 4 2 39 51 48 22 13 10 13 8 20 49
2022/2023318 50 71 26 12 16 22 17 4 66 0 34 0
2023/2024379 2 9 19 3 28 41 51 36 32 25 66 67
2024/20251.452 26 58 85 118 91 145 142 55 145 159 173 255
2025/2026900 147 114 180 182 195 82 0 0 0 0 0 0
Totale 3.356